Gordon Rustin

26.0k citations
249 papers · 17.0k · 5 hit papers · h-index 69

Impact in

Papers in

    • Ovarian cancer diagnosis and treatment 96
    • Testicular diseases and treatments 55
    • Intraperitoneal and Appendiceal Malignancies 15

Gordon Rustin

248 papers receiving 16.3k citations

Gordon Rustin's Hit Papers

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial 2014 · 1.1k citations
1.1k0+7+14Years since publication50010001.5k

Peers

Gordon Rustin
Comparison fields: 5 of 144
  • Reproductive Medicine 4.3k
  • Oncology 4.6k
  • Obstetrics and Gynecology 890
  • Internal Medicine 375
  • Radiology, Nuclear Medicine and Imaging 2.0k
Replace Andrew Berchuck with:
Andrew Berchuck United States
Gordon C. Jayson United Kingdom
Martin Gore United Kingdom
Jalid Sehouli Germany
John D. Hainsworth United States
Amit M. Oza Canada
David M. Gershenson United States
William T. Creasman United States
Richard I. Fisher United States
D. Lawrence Wickerham United States
Gordon Rustin relative to Andrew Berchuck United States Andrew Berchuck's profile →
Citations per field
00.5×2×3×3.6×
Andrew Berchuck · 1×
Citations per year

Countries citing papers authored by Gordon Rustin

Since Specialization
Citations

This map shows the geographic impact of Gordon Rustin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Rustin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Rustin more than expected).

Fields of papers citing papers by Gordon Rustin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Rustin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Rustin. The network helps show where Gordon Rustin may publish in the future.

Co-authors

The 25 scholars most cited alongside Gordon Rustin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gordon Rustin Line = papers co-authored together Gordon Rustin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 249 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
Hit paper breakdown →
20091653
2
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Hit paper breakdown →
20121413
3
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Hit paper breakdown →
20141102
4
Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
Hit paper breakdown →
2004536
5
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
Hit paper breakdown →
2010395
6 2016324
7 2002294
8 2003289
9 2003283
10 1997251
11
Phase I trial of temozolomide using an extended continuous oral schedule.
1998239
12 1995232
13 2005230
14 2000221
15 2003195
16 2002192
17 2011189
18 2011175
19 2016173
20 2000169

About Gordon Rustin

Gordon Rustin is a scholar working on Reproductive Medicine, Surgery, Oncology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 249 papers that have together received 17.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (96 papers), Testicular diseases and treatments (55 papers), Gestational Trophoblastic Disease Studies (32 papers), PARP inhibition in cancer therapy (27 papers), Endometrial and Cervical Cancer Treatments (15 papers), Intraperitoneal and Appendiceal Malignancies (15 papers), Neuroblastoma Research and Treatments (12 papers) and Lung Cancer Research Studies (12 papers). The work is most often cited by research in Reproductive Medicine (4.3k citations), Oncology (4.6k citations), Obstetrics and Gynecology (890 citations), Internal Medicine (375 citations) and Radiology, Nuclear Medicine and Imaging (2.0k citations). Gordon Rustin has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include E.S. Newlands, Richard H. J. Beǵent, L. Holden, Jonathan A. Ledermann, Anwar R. Padhani, K. D. Bagshawe, Michael Friedländer, Charlie Gourley, Ignace Vergote and Werner Meier. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, European Journal of Cancer and International Journal of Gynecological Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact